Triazolones as fatty acid synthase inhibitors

A compound of Formula (I),

• wherein,
• R1 is a 6-membered aryl or heteroaryl ring which may be substituted or unsubstituted, in which adjacent substituents together may form an additional optionally substituted five or six membered ring which contains 0-3 heteroatoms and 0 to 2 double bonds;
• each R3 is independently selected from the group consisting of:
• halogen, C1-6alkyl, hydroxyl, and alkoxy;
• R4 is H or C1-6alkyl;
• R5 is selected from the group consisting of:
• C1-6alkyl, C3-7cycloalkyl, —OC1-6alkyl, C4-6heterocycloalkyl, amino and alkylamino;
• m is 0-3, n is 0-1;
• or a pharmaceutically acceptable salt thereof.